Predict your next investment

Corporation
HEALTHCARE | Medical Equipment & Supplies
bio-gp.com.cn

See what CB Insights has to offer

Stage

IPO | IPO

Total Raised

$16.07M

Date of IPO

7/17/2017

About Jidan Biotechnology

Provider of in-vitro diagnostic solutions. The company specializes in analytical medical devices, point-of-care testing (POCT) kits, clinical chemistry reagents, raw materials, and molecular diagnostic kits. It also provides pre- and post-sales service and technical support.

Jidan Biotechnology Headquarter Location

9 Bofu Road Zhongshan Technology Park

Nanjing, Jiangsu, 211505,

China

86 25 68568588

Latest Jidan Biotechnology News

Global Coronavirus Testing Kits Market, By Type of Test, By Use, By Full Test Time, By Technology, By Specimen Type, By Mobility, By End Use, By Region, Competition Forecast & Opportunities, 2026

Jun 3, 2021

Use, By Full Test Time, By Technology, By Specimen Type, By Mobility, By End Use, By Region, Competition Forecast & Opportunities, 2026" - https://www.reportlinker.com/p06089426/?utm_source=GNW Global coronavirus testing kits market was valued USD50697.36 million in 2020 due to the rising cases and need for testing. The global coronavirus testing kits market is driven by the increasing prevalence of infectious diseases across different parts of the globe. Additionally, governments across the globe are trying to avail testing kits in the shortest time so that they can quickly test for the disease and take necessary precautions and provide treatment to combat its spread. Furthermore, various pharmaceutical and biotechnology companies are collaborating to increase the production of coronavirus testing kits. This in turn is anticipated to positively impact the market growth. The ongoing novel coronavirus disease (COVID-19) is caused due to SARS-COV-2 and generally spreads from animals to humans and then from humans to humans.The disease usually spreads from saliva droplets or the nose discharges of the infected person when they cough or sneeze. The first case of the disease was reported in December 2019 in Wuhan, China and since then it has spread to various parts of the world, infecting millions. The global coronavirus testing kits market is segmented based on type of test, use, full test time, technology, specimen type, mobility, end user, company and region.Based on technology, the market can be categorized into RT-PCR, Rapid Diagnostics Test, ELISA test and others. The RT-PCR segment is anticipated to dominate the market during the forecast period on account of its accuracy, specificity and sensitivity.Additionally, RT-PCR can detect as little as one virus particle present in the swab. Based on end user, the market can be fragmented into public health labs, hospitals, private or commercial labs, physician labs, others. The private or commercial labs segment is expected to register significant growth since such laboratories have got approval in many countries for aggressive COVID-19 testing. Regionally, the global coronavirus testing kits market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa.Among these, Europe dominates the global coronavirus testing kits market owing to the presence of many pharmaceutical and biotechnology companies such as Altona Diagnostics GmbH, Roche Holding AG, Siemens, among others in the region, which are rapidly manufacturing and supplying coronavirus testing kits. Additionally, Europe was the first region to develop RT-PCR based coronavirus testing kits. Major players operating in the global coronavirus testing kits market include Abbott Laboratories, Altona Diagnostics GmbH, Roche Holding AG, BioMedomics Inc., Getein Biotech Inc, Hangzhou Biotest Biotech Company Ltd., AmonMed Biotechnology Co. Ltd., Beijing Tigsun Diagnostics Co Ltd., CTK Biotech Inc., Hunan Lituo Biotechnology Co. Ltd., Vivacheck Labaratories Inc., Thermo Fisher Scientific Inc., Siemens AG, Seegene Technologies Inc., FastSense Diagnostics Pvt. Ltd., Quest Diagnostics Inc., Quidel Corporation, Becton Dickinson and Company, QIAGEN N.V., PerkinElmer Inc. and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments. For instance, in March 2020, Abbott Laboratories announced the launch of a small and portable coronavirus test kit, which can detect if someone is infected, in just 5 minutes and can be used in almost any healthcare setting. Years considered for this report: Historical Years: 2016-2019

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Jidan Biotechnology

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Jidan Biotechnology is included in 1 Expert Collection, including Health Monitoring & Diagnostics.

H

Health Monitoring & Diagnostics

701 items

Companies developing technology to facilitate near-patient and point-of-care (POC) in vitro diagnostic testing. Companies tagged as #NearPatient&POCTesting

Jidan Biotechnology Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Jidan Biotechnology Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.